Significance and therapeutic implications of tumor regression following radiotherapy in patients treated for squamous cell carcinoma of the oropharynx and pharyngolarynx-Reference-Cited by-同舟云学术

Significance and therapeutic implications of tumor regression following radiotherapy in patients treated for squamous cell carcinoma of the oropharynx and pharyngolarynx

Published:1990-01 Issue:1 Volume:12 Page:41-49
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head Neck

Author:

Bataini Jean P.,Jaulerry Christian,Brunin Francoise,Ponvert Dominic,Ghossein Nemetallah A.

Publisher

Wiley

Subject

Otorhinolaryngology

Reference27 articles.

1. Tumour regression during radiation treatment as a guide to prognosis

2. Short-term persistence of carcinoma of the uterine cervix after radiation. An indicator of long-term prognosis

3. The Significance of Residual Disease after External Irradiation of Squamous-Cell Carcinoma of the Oropharynx

4. Impact of neck node radioresponsiveness on the regional control probability in patients with oropharynx and pharyngolarynx cancers managed by definitive radiotherapy

5. , , , eds. International Union against cancer TNM atlas. Berlin: Springer-Verlag, 1985.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying the prognostic value of MRI-based tumor response and predicting the risk of radio-resistance in re-radiotherapy for locally recurrent nasopharyngeal carcinoma;Radiotherapy and Oncology;2023-06

2. Hypopharyngeal Cancer: Staging, Diagnosis, and Therapy;Pharynx - Diagnosis and Treatment;2021-09-08

3. Longitudinal characterization of the tumoral microbiome during radiotherapy in HPV-associated oropharynx cancer;Clinical and Translational Radiation Oncology;2021-01

4. Longitudinal Characterization of the Tumoral Microbiome during Radiotherapy in HPV-associated Oropharynx Cancer;2020-06-09

5. Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma;Radiotherapy and Oncology;2019-03